Podcast: Patients, Not Profits, Should Drive Drug Discovery | Vibe Bio, Alok Tayi
Alok Tayi joins Santiago Santos to discuss how Vibe Bio is leveraging crypto to fund research and development for rare diseases
In this episode of Empire, Santi is joined by Alok Tayi, scientist and founder of Vibe Bio. Alok started Vibe Bio because the biggest obstacle in treating patients with overlooked diseases isn’t finding potential treatments — it’s funding them.
Vibe Bio is leveraging crypto’s economic and coordination tools to fund the research and development that the legacy biotech industry ignores. Don’t miss this fascinating conversation!
- Vibe Bio’s origin story and how it works
- Big pharma’s dilemma
- Why these diseases don’t receive funding today
- Project prioritization
- Crypto’s unique advantages
- The $VIBE token
- How to grow and leverage Vibe’s community
- Diseases don’t care about interest rates
- Biggest challenges
Check out what they had to say in the video below.👇
About the show
“Empire” is a twice-a-week show where we share the real crypto stories that aren’t heard elsewhere. On Mondays, Jason Yanowitz and Santiago Santos interview crypto industry movers and shakers to talk about their struggles, bold moves and tough decisions. Finish off the week with Friday’s weekly roundup episode that covers the top news and narratives of the week.
For any NPR or Guy Raz fans out there, you can think of “Empire” as a “How I Built This” for Web3.
Don’t miss the next big story – join our free daily newsletter.
Follow Sam Bankman-Fried’s trial with the latest news from the courtroom.